The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Final analysis of single-arm confirmatory study of diagnostic endoscopic resection(ER) plus selective chemoradiotherapy (CRT) for stage I esophageal squamous cell carcinoma (ESCC): JCOG0508.
 
Keiko Minashi
No Relationships to Disclose
 
Keiji Nihei
No Relationships to Disclose
 
Gakuto Ogawa
No Relationships to Disclose
 
Kohei Takizawa
Honoraria - AstraZeneca; Eisai; Olympus
 
Tomonori Yano
Honoraria - AstraZeneca; Eisai; Olympus
 
Yusuke Amanuma
Research Funding - Taiho Pharmaceutical
 
Tomohiro Tsuchida
No Relationships to Disclose
 
Hiroyuki Ono
No Relationships to Disclose
 
Toshiro Iizuka
Honoraria - AstraZeneca; Eisai; Fujifilm; GUNZE LIMITED
 
Satoki Shichijyo
No Relationships to Disclose
 
Ichiro Oda
No Relationships to Disclose
 
Yoshinori Morita
No Relationships to Disclose
 
Masahiro Tajika
Speakers' Bureau - Ajinomoto
Research Funding - Ajinomoto (Inst)
 
Junko Fujiwara
No Relationships to Disclose
 
Yoshinobu Yamamoto
No Relationships to Disclose
 
Chikatoshi Katada
No Relationships to Disclose
 
Shinichiro Hori
Honoraria - Eisai
 
Hisashi Doyama
No Relationships to Disclose
 
Haruhiko Fukuda
Honoraria - Chugai Pharma; Taiho Pharmaceutical
 
Manabu Muto
Consulting or Advisory Role - Eisai; Kewpie
Research Funding - Chugai Pharma; Mitsui Knowledge Industry; Olympus; Pfizer; Taiho Pharmaceutical; Theravalues Corporation